Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-12

Clinical Trial Update: Dexmedetomidine on Microcirculation in Septic Shock [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexmedetomidine effects on microcirculation in septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Southeast University, China | Conditions: Septic Shock | Phase 4 | Status: COMPLETED